If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAmati Aim Vct Regulatory News (AMAT)

  • There is currently no data for AMAT

Strategic Review

14 Mar 2024 07:00

RNS Number : 7782G
Amati AIM VCT PLC
14 March 2024
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION DIRECTLY OR INDIRECTLY (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICITON WHERE TO DO SO WOULD COSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THE JURISDICITON.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATON FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON THE PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

For immediate release

14 March 2024

Amati AIM VCT plc

 

Strategic review

 

The Board of Amati AIM VCT plc (the "Company") confirms that it has, in conjunction with the Company's investment manager, Amati Global Investors Limited (the "Investment Manager"), been considering the Company's strategic options in the light of ongoing challenges in the AIM market and the resultant performance issues faced by the Company. As part of this review, the Board intends to consider whether the Company's investment strategy should be expanded to facilitate investment in a broader range of securities while continuing to comply with the rules applicable to VCTs. 

 

The Board also notes the recent announcement of a recommended offer (the "Offer") for Mattioli Woods plc by Tiger Bidco Limited (owned by funds managed by Pollen Street Capital Limited). Mattioli Woods plc currently owns 49% of the issued share capital of the Investment Manager. The ongoing review of strategic options will take into account any possible impact of the Offer on the Company and the management of its investment portfolio.

 

Further details of the strategic review will be included in the Company's annual report and accounts which are expected to be published shortly.

 

Enquiries:

 

Fiona Wollocombe, Chair

Amati AIM VCT plc

Email: info@amatiglobal.com

 

Douglas Armstrong

Dickson Minto Advisers

Financial Adviser to the Company

Telephone: 020 7649 6823

 

Important Information

This announcement is released by the Company and the information contained within this announcement is deemed by the Company to constitute inside information for the purposes of Article 7 of the UK version of the EU Market Abuse Regulation (Regulation (EU) No.596/2014) which forms part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended. Upon the publication of this announcement via a Regulatory Information Service, such information is now considered to be in the public domain.

Legal Entity Identifier (LEI): 213800HAEDBBK9RWCD25

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDSFMFUDELSEID
Date   Source Headline
1st Apr 20207:53 amRNSTotal Voting Rights
31st Mar 202010:11 amRNSIssue of Equity
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 20205:26 pmRNSHolding(s) in Company
27th Mar 20204:49 pmRNSNet Asset Value(s)
27th Mar 20209:51 amRNSTransaction in Own Shares
26th Mar 20207:37 amRNSIssue of Equity - replacement
24th Mar 202010:48 amRNSIssue of Equity
23rd Mar 202011:42 amRNSNet Asset Value(s)
20th Mar 20203:37 pmRNSHolding(s) in Company
19th Mar 20207:39 amRNSIssue of Equity - replacement
18th Mar 202012:32 pmRNSDirector/PDMR Shareholding
18th Mar 202012:29 pmRNSIssue of Equity
16th Mar 20203:15 pmRNSNet Asset Value(s)
16th Mar 202012:49 pmRNSTransaction in Own Shares
12th Mar 20204:14 pmRNSTransaction in Own Shares
12th Mar 202011:06 amRNSTransaction in Own Shares
10th Mar 20202:55 pmRNSTransaction in Own Shares
6th Mar 20203:43 pmRNSNet Asset Value(s)
6th Mar 202012:30 pmRNSTransaction in Own Shares
3rd Mar 20205:01 pmRNSDirector/PDMR Shareholding
3rd Mar 20204:17 pmRNSIssue of Equity
3rd Mar 20209:38 amRNSNet Asset Value(s)
2nd Mar 20208:30 amRNSTotal Voting Rights
25th Feb 202012:17 pmRNSTransaction in Own Shares
24th Feb 202012:06 pmRNSTransaction in Own Shares
24th Feb 202010:03 amRNSNet Asset Value(s)
21st Feb 20203:14 pmRNSTransaction in Own Shares
14th Feb 20204:37 pmRNSNet Asset Value(s)
11th Feb 20205:29 pmRNSDirector/PDMR Shareholding
11th Feb 20205:05 pmRNSReplacement Transaction in Own Shares
11th Feb 20204:53 pmRNSIssue of Equity
11th Feb 20203:40 pmRNSTransaction in Own Shares
10th Feb 20203:20 pmRNSTransaction in Own Shares
7th Feb 20204:31 pmRNSNet Asset Value(s)
7th Feb 202011:58 amRNSTransaction in Own Shares
4th Feb 20209:42 amRNSNet Asset Value(s)
3rd Feb 202012:33 pmRNSTransaction in Own Shares
3rd Feb 202010:34 amRNSTotal Voting Rights
27th Jan 20202:43 pmRNSHolding(s) in Company
24th Jan 20204:20 pmRNSNet Asset Value(s)
23rd Jan 20202:17 pmRNSTransaction in Own Shares
22nd Jan 202012:35 pmRNSTransaction in Own Shares
20th Jan 202010:12 amRNSNet Asset Value(s)
17th Jan 20203:32 pmRNSHolding(s) in Company
17th Jan 202011:56 amRNSDirector Declaration
14th Jan 20202:22 pmRNSTransaction in Own Shares
14th Jan 202010:40 amRNSIssue of Equity
10th Jan 20204:11 pmRNSNet Asset Value(s)
8th Jan 20204:13 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.